Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASCAL
NCT00389792Phase 2Completed
- Sponsor
- ARYx Therapeutics
- Start
- Jul 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of budiodarone in Atrial fibrillation (AFib), sponsored by ARYx Therapeutics. Started Jul 2006; status: completed.
02
Drugs
budiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00389792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389792.